Latest: FDA Approves New Biosimilar for Oncology Treatment

Exploring Orexin Neuron Loss as an Early Driver of Sleep Disturbances in Alzheimer Disease

by Neurology Live

14 September, 2025

0 Mins

Lea Grinberg, MD, PhD, a neuropathologist at Mayo Clinic Florida, discussed how tau accumulation and orexin neuron loss drive early sleep disturbances in Alzheimer disease and the potential for sleep-based biomarkers.

Tags:

Author

Neurology Live

Using Telemedicine to Keep Care Local

Efficient Strategies to Reduce Wait Time Between Diagnosis of Hidradenitis Suppurativa and Treatment

📢

300x250 Banner

Exploring Orexin Neuron Loss as an Early Driver of Sleep Disturbances in Alzheimer Disease

Tags:

Neurology Live

Using Telemedicine to Keep Care Local

Efficient Strategies to Reduce Wait Time Between Diagnosis of Hidradenitis Suppurativa and Treatment

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition